Artículos por temáticas

Subthalamic suppression defines therapeutic threshold of deep brain stimulation in Parkinson's disease.

Milosevic L, Kalia SK, Hodaie M, Lozano A, Popovic MR, Hutchison W.

J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1105-1108. doi: 10.1136/jnnp-2019-321140. Epub 2019 Aug 17.

Edaravone-caffeine combination for the effective management of rotenone induced Parkinson's disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression.

Bandookwala M, Sahu AK, Thakkar D, Sharma M, Khairnar A, Sengupta P.

Neurosci Lett. 2019 Oct 15;711:134438. doi: 10.1016/j.neulet.2019.134438. Epub 2019 Aug 15.

Graph theory and network topological metrics may be the potential biomarker in Parkinson's disease.

Huang LC, Wu PA, Lin SZ, Pang CY, Chen SY.

J Clin Neurosci. 2019 Oct;68:235-242. doi: 10.1016/j.jocn.2019.07.082. Epub 2019 Aug 13.

Deep brain stimulation induced normalization of the human functional connectome in Parkinson's disease.

Horn A, Wenzel G, Irmen F, Huebl J, Li N, Neumann WJ, Krause P, Bohner G, Scheel M, Kühn AA.

Brain. 2019 Oct 1;142(10):3129-3143. doi: 10.1093/brain/awz239.

Neuroprotective effects of increasing levels of HSP70 against neuroinflammation in Parkinson's disease model by inhibition of NF-κB and STAT3.

Li H, Yang J, Wang Y, Liu Q, Cheng J, Wang F.

Life Sci. 2019 Oct 1;234:116747. doi: 10.1016/j.lfs.2019.116747. Epub 2019 Aug 10.

Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease.

García-Moreno CJ, Porta de la Riva M, Martínez-Lara E, Siles E, Cañuelo A.

Neurobiol Aging. 2019 Oct;82:60-68. doi: 10.1016/j.neurobiolaging.2019.07.003. Epub 2019 Jul 11.

Immediate effects of rhythmic auditory stimulation on gait kinematics in Parkinson's disease ON/OFF medication.

Erra C, Mileti I, Germanotta M, Petracca M, Imbimbo I, De Biase A, Rossi S, Ricciardi D, Pacilli A, Di Sipio E, Palermo E, Bentivoglio AR, Padua L.

Clin Neurophysiol. 2019 Oct;130(10):1789-1797. doi: 10.1016/j.clinph.2019.07.013. Epub 2019 Jul 25.

Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model.

Yang C, Mo Y, Xu E, Wen H, Wei R, Li S, Zheng J, Li W, Le B, Chen Y, Pan H, Huang S, Wang S, Wang Q.

Int Immunopharmacol. 2019 Oct;75:105651. doi: 10.1016/j.intimp.2019.05.036. Epub 2019 Aug 8.

Exercise in Parkinson's disease: Experimental-induced pain sensitivity is reduced already after short term training.

Mylius V.

Eur J Pain. 2019 Oct;23(9):1585. doi: 10.1002/ejp.1468. Epub 2019 Aug 28. No abstract available.

Oral Silica Nanoparticles Lack of Neurotoxic Effects in a Parkinson's Disease Model: A Possible Nanocarrier?

Guzman-Ruiz MA, de La Mora MB, Torres X, Meza C, Garcia E, Chavarria A.

IEEE Trans Nanobioscience. 2019 Oct;18(4):535-541. doi: 10.1109/TNB.2019.2934074. Epub 2019 Aug 8.

Discussing sexuality with Parkinson's disease patients: a multinational survey among neurologists.

de Rooy FBB, Buhmann C, Schönwald B, Martinez-Martin P, Rodriguez-Blazquez C, Putter H, Elzevier HW, van der Plas AA.

J Neural Transm (Vienna). 2019 Oct;126(10):1273-1280. doi: 10.1007/s00702-019-02053-5. Epub 2019 Aug 8.

Relationship between 25-Hydroxyvitamin D, bone density, and Parkinson's disease symptoms.

Zhang HJ, Zhang JR, Mao CJ, Li K, Wang F, Chen J, Liu CF.

Acta Neurol Scand. 2019 Oct;140(4):274-280. doi: 10.1111/ane.13141. Epub 2019 Aug 6.

The therapeutic effect of deep brain stimulation on olfactory functions and clinical scores in Parkinson's disease.

Saatçi Ö, Yılmaz NH, Zırh A, Yulug B.

J Clin Neurosci. 2019 Oct;68:55-61. doi: 10.1016/j.jocn.2019.07.055. Epub 2019 Aug 2.

Risk of pneumonia associated with atypical antipsychotic use in nursing home residents with Parkinson's disease.

Chekani F, Holmes HM, Johnson ML, Chen H, Sherer JT, Aparasu RR.

J Psychiatr Res. 2019 Oct;117:116-121. doi: 10.1016/j.jpsychires.2019.07.005. Epub 2019 Jul 26.

Probabilistic sweet spots predict motor outcome for deep brain stimulation in Parkinson disease.

Dembek TA, Roediger J, Horn A, Reker P, Oehrn C, Dafsari HS, Li N, Kühn AA, Fink GR, Visser-Vandewalle V, Barbe MT, Timmermann L.

Ann Neurol. 2019 Oct;86(4):527-538. doi: 10.1002/ana.25567.